Certolizumab pegol Completed Phase 3 Trials for Psoriatic Arthritis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01087788Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis